Home  |  About JAPTR |  Editorial board  |  Search |  Ahead of print  |  Current issue  |  Archives |  Submit article  |  Instructions  |  Subscribe  |  Advertise  |  Contacts  |Login 
Users Online: 14   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
     
This article has been cited by
1Pattern and Appropriateness of Medicines Prescribed to Outpatients at a University Hospital in Northwestern Ethiopia
Fitsum Sebsibe Teni,Sewunet Admasu Belachew,Begashaw Melaku Gebresillassie,Eshetie Melese Birru,Befikadu Legesse Wubishet,Bethelhem Hailu Tekleyes,Bilal Tessema Yimer,Yonas Getaye Tefera
BioMed Research International.2017;2017()1
[DOI]
2The Cancer Drug Fraction of Metabolism Database
Liyan Hua,Chien-Wei Chiang,Wang Cong,Jin Li,Xueying Wang,Lijun Cheng,Weixing Feng,Sara K. Quinney,Lei Wang,Lang Li
CPT: Pharmacometrics & Systems Pharmacology.2019;8(7)511
[DOI]
3Drug-drug interaction software in clinical practice: a systematic review
Tina Roblek,Tomaz Vaupotic,Ales Mrhar,Mitja Lainscak
European Journal of Clinical Pharmacology.2015;71(2)131
[DOI]
4Assessment of Drug-Drug Interaction in Ayder Comprehensive Specialized Hospital, Mekelle, Northern Ethiopia: A Retrospective Study
Zeru Gebretsadik,Micheale Gebrehans,Desalegn Getnet,Desye Gebrie,Tsgab Alema,Yared Belete Belay
BioMed Research International.2017;2017(2)1
[DOI]
5Prevalence of potential drug-drug interactions and associated factors among outpatients and inpatients in Ethiopian hospitals: a systematic review and meta-analysis of observational studies
Wondim Ayenew,Getahun Asmamaw,Arebu Issa
BMC Pharmacology and Toxicology.2020;21(1)1
[DOI]
6Prevalence and nature of potential drug-drug interactions among hospitalized HIV patients presenting with suspected meningitis in Uganda
Prosperity C. Eneh,Katherine Huppler Hullsiek,Daniel Kiiza,Joshua Rhein,David B. Meya,David R. Boulware,Melanie R. Nicol
BMC Infectious Diseases.2020;20(1)1
[DOI]
7

Real-World Analysis of Potential Pharmacokinetic and Pharmacodynamic Drug Interactions with Apixaban in Patients with Non-Valvular Atrial Fibrillation

Hisham A Badreldin,Jahad Alghamdi,Omar Alshaya,Abdulmajeed Alshehri,Lamya Alreshoud,Renad Altoukhi,Senthilvel Vasudevan,Wesam Ismail,Mohamed Salih Aziz Mohamed
International Journal of General Medicine.2020;Volume 13(1)419
[DOI]
8Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study
Gebrehiwot Teklay,Nuredin Shiferaw,Befikadu Legesse,Mebratu Bekele
Thrombosis Journal.2014;12(1)20
[DOI]
9Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study
Theresa Stehmer,Stephen A. Bernard
Thrombosis Journal.2015;12(1)157
[DOI]
10Categorization and association analysis of risk factors for adverse drug events
Lina Zhou,Anamika Paul Rupa
European Journal of Clinical Pharmacology.2018;74(4)389
[DOI]
11Prevalence and determinants of polypharmacy in cardiovascular patients attending outpatient clinic in Ethiopia University Hospital
Yonas Getaye Tefera,Mekuriaw Alemayehu,Gashaw Binega Mekonnen,Samson Gebremedhin
PLOS ONE.2020;15(6)e0234000
[DOI]
12Occurrence of drug–drug interactions in Adama Referral Hospital, Adama city, Ethiopia
Thirumurugan Gunasekaran,Natsanet Dejene,Vanapalli V. Satyaveni,Magharla Dasaratha Dhanaraju
Journal of Drug Assessment.2015;4(1)19
[DOI]
  Feedback 
  Subscribe 




Most popular articles
Join us as a reviewer
Email alerts
Recommend this journal